Allogeneic HSCT for Symptomatic Female X-linked Chronic Granulomatous Disease Carriers.

MLA

Tsilifis, Christo, et al. “Allogeneic HSCT for Symptomatic Female X-Linked Chronic Granulomatous Disease Carriers.” Journal of Clinical Immunology, vol. 43, no. 8, Nov. 2023, pp. 1964–73. EBSCOhost, https://doi.org/10.1007/s10875-023-01570-z.

APA

Tsilifis, C., Torppa, T., Williams, E. J., Albert, M. H., Hauck, F., Soncini, E., Kang, E., Malech, H., Schuetz, C., von Bernuth, H., Slatter, M. A., & Gennery, A. R. (2023). Allogeneic HSCT for Symptomatic Female X-linked Chronic Granulomatous Disease Carriers. Journal of Clinical Immunology, 43(8), 1964–1973. https://doi.org/10.1007/s10875-023-01570-z

Chicago

Tsilifis, Christo, Tuulia Torppa, Eleri J. Williams, Michael H. Albert, Fabian Hauck, Elena Soncini, Elizabeth Kang, et al. 2023. “Allogeneic HSCT for Symptomatic Female X-Linked Chronic Granulomatous Disease Carriers.” Journal of Clinical Immunology 43 (8): 1964–73. doi:10.1007/s10875-023-01570-z.